A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance - Trial NCT06313255
Access comprehensive clinical trial information for NCT06313255 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Recruiting. The study focuses on Chronic Hepatitis B. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Qilu Hospital of Shandong University
Timeline & Enrollment
N/A
May 09, 2023
Dec 31, 2025
Primary Outcome
HBsAg clearance
Summary
The goal of this retrospective observational study is to find out the effects of probiotics
 on HBV clearance. The main question it aims to answer is:
 
 Are the probiotics have an effect in promoting HBV clearance? The participants will observe
 the HBV clearance rate in chronic hepatitis B patients receive probiotics in addition to the
 routine antiviral therapy.
 
 Researchers will compare the HBV clearance rate in chronic hepatitis B patients receive
 probiotics and antiviral therapy with those receiving solely antiviral therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06313255
Non-Device Trial